The Effect of Atenolol on CK-MB Levels in Hypertensive Patients

Atenolol is one of beta-adrenergic receptor blocking agent. It is widely used for the treatment of hypertension as a selective antihypertensive drug. But long term usage of atenolol may cause one of the cardiovascular diseases like myocardial infarction. To prove the relationship between atenolol an...

Full description

Bibliographic Details
Main Author: Inaam A. Amin
Format: Article
Language:English
Published: College of Pharmacy University of Baghdad 2017-03-01
Series:Iraqi Journal of Pharmaceutical Sciences
Online Access:https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/323
_version_ 1819227612270034944
author Inaam A. Amin
author_facet Inaam A. Amin
author_sort Inaam A. Amin
collection DOAJ
description Atenolol is one of beta-adrenergic receptor blocking agent. It is widely used for the treatment of hypertension as a selective antihypertensive drug. But long term usage of atenolol may cause one of the cardiovascular diseases like myocardial infarction. To prove the relationship between atenolol and cardiovascular disease, measurement of creatinekinase-MB as a diagnostic indicator in early and long term usage of this drug by hypertensive patients is recommended.  A comparative study was conducted in Al-Yarmouk Teaching Hospital–Emergency Department- on 30 hypertensive patients using atenolol. They were divided into (2) groups A and B according to the duration of the drug usage. Group A- (15) patients with a mean age (56+6) years. They used atenolol for a period of (1-5) years. Group B- also (15) patients with mean age (60+6) years. They used atenolol for (6-20) years. Both groups were with nearly the same number of males and females. All subjects of the study groups were screened to exclude evidence of hyper or hypothyroidism, diabetes and chronic renal failure. Venous blood samples were taken in first 8 hours after onset symptoms of cardiac attack from each patients and the levels of creatine kinase-MB were estimated and compared between the (2) groups. There is a significant correlation between levels of serum creatine kinase-MB of group A and group B (P<0.05). Atenolol causes increased level of serum CK-MB and this increase was directly proportional to the duration of the drug usage. CK-MB is one of cardiac markers that released from heart muscle when it is damaged as a result of myocardial infraction. So, atenolol has a significant correlation with development of myocardial diseases. Key words:  hypertension ,  Atenolol  and  side  effects ,  creatine kinase-MB ,  Atenolol antihypertensive.
first_indexed 2024-12-23T10:44:09Z
format Article
id doaj.art-3bb12d1f845d4928accf736f8c90d680
institution Directory Open Access Journal
issn 2521-3512
1683-3597
language English
last_indexed 2024-12-23T10:44:09Z
publishDate 2017-03-01
publisher College of Pharmacy University of Baghdad
record_format Article
series Iraqi Journal of Pharmaceutical Sciences
spelling doaj.art-3bb12d1f845d4928accf736f8c90d6802022-12-21T17:50:05ZengCollege of Pharmacy University of BaghdadIraqi Journal of Pharmaceutical Sciences2521-35121683-35972017-03-01181The Effect of Atenolol on CK-MB Levels in Hypertensive PatientsInaam A. AminAtenolol is one of beta-adrenergic receptor blocking agent. It is widely used for the treatment of hypertension as a selective antihypertensive drug. But long term usage of atenolol may cause one of the cardiovascular diseases like myocardial infarction. To prove the relationship between atenolol and cardiovascular disease, measurement of creatinekinase-MB as a diagnostic indicator in early and long term usage of this drug by hypertensive patients is recommended.  A comparative study was conducted in Al-Yarmouk Teaching Hospital–Emergency Department- on 30 hypertensive patients using atenolol. They were divided into (2) groups A and B according to the duration of the drug usage. Group A- (15) patients with a mean age (56+6) years. They used atenolol for a period of (1-5) years. Group B- also (15) patients with mean age (60+6) years. They used atenolol for (6-20) years. Both groups were with nearly the same number of males and females. All subjects of the study groups were screened to exclude evidence of hyper or hypothyroidism, diabetes and chronic renal failure. Venous blood samples were taken in first 8 hours after onset symptoms of cardiac attack from each patients and the levels of creatine kinase-MB were estimated and compared between the (2) groups. There is a significant correlation between levels of serum creatine kinase-MB of group A and group B (P<0.05). Atenolol causes increased level of serum CK-MB and this increase was directly proportional to the duration of the drug usage. CK-MB is one of cardiac markers that released from heart muscle when it is damaged as a result of myocardial infraction. So, atenolol has a significant correlation with development of myocardial diseases. Key words:  hypertension ,  Atenolol  and  side  effects ,  creatine kinase-MB ,  Atenolol antihypertensive.https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/323
spellingShingle Inaam A. Amin
The Effect of Atenolol on CK-MB Levels in Hypertensive Patients
Iraqi Journal of Pharmaceutical Sciences
title The Effect of Atenolol on CK-MB Levels in Hypertensive Patients
title_full The Effect of Atenolol on CK-MB Levels in Hypertensive Patients
title_fullStr The Effect of Atenolol on CK-MB Levels in Hypertensive Patients
title_full_unstemmed The Effect of Atenolol on CK-MB Levels in Hypertensive Patients
title_short The Effect of Atenolol on CK-MB Levels in Hypertensive Patients
title_sort effect of atenolol on ck mb levels in hypertensive patients
url https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/323
work_keys_str_mv AT inaamaamin theeffectofatenololonckmblevelsinhypertensivepatients
AT inaamaamin effectofatenololonckmblevelsinhypertensivepatients